Glenmark gets USFDA nod to market generic diabetes drug
Glenmark gets USFDA nod to market generic diabetes drug
The company has received final approval from the US Food & Drug Administration (US FDA) for Saxagliptin Tablets (2.5 mg and 5 mg), the generic version of AstraZeneca's Onglyza1…
Read More...
Read More...